1. Home
  2. Live Updates
  3. Manojna maddipatla

Live Breaking News & Updates on Manojna maddipatla

Stay informed with the latest breaking news from Manojna maddipatla on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Manojna maddipatla and stay connected to the pulse of your community

U.S. authorizes second COVID booster for Americans 50 and older

By Michael Erman and Manojna Maddipatla

United-states , Bengaluru , Karnataka , India , New-jersey , Israel , Washington , Americans , Israeli , Manojna-maddipatla , Ahmed-aboulenein , Peter-marks

Johnson & Johnson to Suspend Supply of Personal Care Products to Russia

Johnson & Johnson said on Tuesday it would halt sale of personal care products in Russia, joining other companies that have limited their business in

Bengaluru , Karnataka , India , Russia , Ukraine , Belarus , Ukrainian , Manojna-maddipatla , Volodymyr-zelenskiy , Shinjini-ganguli , Eli-lilly , Pfizer

U.S. authorizes second COVID booster for Americans 50 and older

By Michael Erman and Manojna Maddipatla (Reuters) - U.S. health officials on Tuesday authorized a second COVID-19 booster dose of the two most commonly

United-states , Bengaluru , Karnataka , India , New-jersey , Israel , Washington , Americans , Israeli , Manojna-maddipatla , Ahmed-aboulenein , Peter-marks

FDA says current dose of GSK, Vir COVID therapy likely not effective against BA.2 variant

(Reuters) - The U.S. health regulator has determined that the current authorized dose of GlaxoSmithKline Plc and Vir Biotechnology's antibody-based CO...

Bengaluru , Karnataka , India , Manojna-maddipatla , Shailesh-kuber , Glaxosmithkline-plc , Reuters , Vir-biotechnology ,

FDA says current dose of GSK, Vir COVID therapy likely not effective against BA.2 variant

(Reuters) - The U.S. health regulator has determined that the current authorized dose of GlaxoSmithKline Plc and Vir Biotechnology's antibody-based CO...

Bengaluru , Karnataka , India , Manojna-maddipatla , Shailesh-kuber , Glaxosmithkline-plc , Reuters , Vir-biotechnology ,

FDA probe of Abbott facility finds quality control issues

(Reuters) - An inspection at the Abbott Laboratories facility in Sturgis, Michigan found a harmful bacteria on surfaces in some areas of its powdered ...

Bengaluru , Karnataka , India , Michigan , United-states , Manojna-maddipatla , Devika-syamnath , Drug-administration , Abbott-laboratories , Reuters ,

U.S. FDA approves Novartis therapy for prostate cancer

(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Novartis AG's therapy for the treatment of adult patients with a certain type ...

Bengaluru , Karnataka , India , Manojna-maddipatla , Shounak-dasgupta , Novarti-pluvicto , Drug-administration-on , Reuters , Drug-administration ,

WHO says there were 64 instances of attacks on health care since Ukraine war started

(Reuters) - The World Health Organization (WHO) said on Thursday it had verified 64 instances of attacks on health care in Ukraine between Feb. 24 and March 21 resulting in 15 deaths and 37 injuries.

Ukraine , Russia , Bengaluru , Karnataka , India , Ukrainians , Russian , Manojna-maddipatla , Shounak-dasgupta , World-health-organization , European-centre-for-disease-prevention , Reuters

Pfizer recalls some lots of BP drug due to potential cancer-causing impurity

Pfizer Inc said on Monday it was recalling some lots of blood pressure drug Accuretic and two authorized cheaper versions of the drug due to the presence of a potential cancer-causing impurity called N-nitroso-quinapril.

Bengaluru , Karnataka , India , Canada , Manojna-maddipatla , Shailesh-kuber , Pfizer , Pfizer-inc , Reuters , Lood-pressure-drug , Mpurity , Ancer-causing

Omicron sub-variant BA.2 makes up about 35% of COVID variants in U.S. – CDC

(Reuters) -The BA.2 sub-variant of Omicron makes up over a third of all coronavirus variants circulating in the United States, according to an estimat...

United-states , Bengaluru , Karnataka , India , Americans , Amy-caren-daniel , Manojna-maddipatla , Manas-mishra , Us-centers-for-disease , Reuters , Disease-control ,